期刊文献+

Ⅲ期食管癌几种不同分割模式照射的疗效观察 被引量:1

Efficacy of stage Ⅲesophageal carcinoma treated by several fractionated radiotherapy
原文传递
导出
摘要 目的比较常规分割剂量每周照射7d,5d及后程加速超分割3种方法治疗Ⅲ期食管癌的疗效及放射反应。方法对138例首治Ⅲ期食管癌病例随机分成A、B、c组。A组46例,2.0Gy/次。5次/周,40—47d完成;B组46例,2.0Gy/次,7次/周,30~35d完成;C组46例,2.0Gy/次,5次/周,4周后,改为1.5Gy/次,2次/d,间隔6h以上,5次/周,35~40d完成。三组累积照射量均为60-70Gy。结果A、B、C组1年生存率分别为32.6%、67.4%、63.0%,3年生存率分别为6.5%、43.5%、41.3%,B、C组高于A组(P〈0.05);1年局部控制率分别为34.8%、71.7%、69.6%,3年局部控制率分别为17.4%、56.5%、56.5%,B、C组高于A组(P〈0.05);出血、穿孔的发生率分别为4.3%、6.5%、4.3%,3组间差异无统计学意义(P〉0.05)。结论常规分割剂量7d/周照射和后程加速超分割照射比5d/周照射可明显提高疗效。 Objective To evaluate the effect of radiotherapy on stage Ⅲesophageal cancer with conventional fraction dose 7-day-per-week and 5-day-per-week and late course accelerated hyperfraction. Method From February 1999 to June 2002 138 patients with stage Ⅲesophageal cancer were divided into 3 groups: group A, B and C. Patients in the A group received a total dose of 60 - 70 Gy/30 - 35 fraction/40 - 47 days, and the B group received a total dose of 60 - 70 Gy/30-35 fraction/30 - 35 days, and the C group received a total dose of 60 - 70 Gy/34 - 40 fraction/37 - 40 days. Results The 1-year survival rates of the A, B, C group were 32.6 %, 67.4 %, 63.0 %(P 〈0.05). The 1-year local tumor control rates of the three group were 34.8 %, 71.7 %, 69.6 %(P 〈0.05). The 3-year survival rates of the A,B,C group were 6.5 %, 43.5 %, 41.3 %(P 〈0.05). The 3-year local tumor control rates of the three group were 17.4 %,56.5 %, 56,5 %(P 〈 0.05). The massive hemorrhage of the three group were 4.3 %, 6.5 %, 4.3 %, (P 〉0.05).Conclusion The 7- day-per-week and the late course accelerated hyperfraction radiotherapy can improve the local tumor control rate and survival rate of stage Ⅲ esophageal cancer.
出处 《肿瘤研究与临床》 CAS 2007年第1期25-26,29,共3页 Cancer Research and Clinic
关键词 食管肿瘤 放射疗法 Esophageal neoplasm Radiotherapy
  • 相关文献

参考文献5

二级参考文献20

共引文献293

同被引文献7

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部